Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease vascular disease
Phenotype C0598608|hyperhomocysteinemia
Sentences 20
PubMedID- 24386282 In other studies, fa acid supplementation has been reported to improve endothelial dysfunction in hyperhomocysteinemia (hhcy) patients with vascular disease [41], [42] including asymptomatic hhcy subjects [43], [44].
PubMedID- 25822522 hyperhomocysteinemia, which is associated with vascular diseases [24,25], birth defects such as spina bifida [26], and neurodegenerative diseases such as alzheimer’s disease [27].
PubMedID- 23791689 Objective: hyperhomocysteinemia is associated with an elevated cardiovascular disease risk.
PubMedID- 23936148 hyperhomocysteinemia has been associated with cardiovascular disease in several prospective studies [18] and numerous explanatory pathomechanisms have been proposed [19-21].
PubMedID- 24847701 Hyperglycemia, dyslipidemia and hyperhomocysteinemia are associated with both adult cardiovascular disease (cvd) and having a child with a congenital heart disease (chd).
PubMedID- 25577237 But other findings showed that hyperhomocysteinemia is a predictor of cardiovascular disease in patients with renal failure as well as chronic stable renal transplant recipients independently of renal function and this is contradictory to the assumption that hyperhomocysteinemia is caused by renal dysfunction [2].
PubMedID- 20227264 hyperhomocysteinemia is associated with cerebro- and cardiovascular disease in industrialized countries, mostly resulting from protein rich diet and sedentary life style.
PubMedID- 22520390 Conclusion: the present study confirms high hyperhomocysteinemia prevalence in patients with extracranial cerebrovascular disease, although no relationship between plaque complication phenomena and this cardiovascular risk factor was observed.
PubMedID- 23569455 Many clinical and epidemiological studies published during the last three decades have shown that even mild hyperhomocysteinemia is associated with vascular disease [6,8,9,10].
PubMedID- 22573925 (2) several studies have elucidated an association of hyperhomocysteinemia with vascular disease independent of the conventional factors.
PubMedID- 26301043 Hypertension, diabetes mellitus, hypercholesterolemia, and hyperhomocysteinemia favour the occurrence of atherosclerosis, cardiovascular diseases, and stroke and represent important risk factors for vad [54].
PubMedID- 23912038 High levels of homocysteine (hcy), known as hyperhomocysteinemia are associated with neurovascular diseases.
PubMedID- 20980407 Folic acid supplementation is regarded as a promising approach for prevention and treatment of cardiovascular disease associated with hyperhomocysteinemia due to its hcy-lowering effect.
PubMedID- 24231341 hyperhomocysteinemia (hhcy) is associated with cardiovascular disease, atherosclerosis and reactive oxygen species generation.
PubMedID- 20091801 Perturbations of homocysteine metabolism, particularly intracellular and subsequently circulating accumulation of homocysteine (i.e., hyperhomocysteinemia), are associated with vascular disease risk, as well as other pathologies.
PubMedID- 25194809 Background and aims: hyperhomocysteinemia (hhcy) is associated with cardiovascular diseases and is thought to induce endogenous oxidative stress and causes many cellular damages.
PubMedID- 22886392 High levels of homocysteine (hcy), known as hyperhomocysteinemia (hhcy), are associated with cerebrovascular diseases, such as vascular dementia, stroke, and alzheimer's disease.
PubMedID- 19267198 Background: homocysteine levels in circulation are determined by several factors and hyperhomocysteinemia is reportedly associated with cardiovascular diseases and dementia.
PubMedID- 19913585 An elevated level of homocysteine (hcy), known as hyperhomocysteinemia (hhcy), was associated with neurovascular diseases.
PubMedID- 24783194 hyperhomocysteinemia is strongly associated with cardiovascular diseases.

Page: 1